These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 6753402)

  • 1. [Diabetic microangiopathy and B-cell residual function. Studies in patients with long-term diabetes mellitus].
    Zick R; Lange P; Sauer H; Mitzkat HJ
    Vasa; 1982; 11(3):183-7. PubMed ID: 6753402
    [No Abstract]   [Full Text] [Related]  

  • 2. C-peptide response to glucagon in diabetics with and without complications.
    Smith RB; Pyke DA; Watkins PJ; Binder C; Faber OK
    N Z Med J; 1979 Apr; 89(634):304-6. PubMed ID: 377156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between the serum level of C-peptide and risk factors for coronary heart disease and diabetic microangiopathy in patients with type-2 diabetes mellitus.
    Inukai T; Matsutomo R; Tayama K; Aso Y; Takemura Y
    Exp Clin Endocrinol Diabetes; 1999; 107(1):40-5. PubMed ID: 10077354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma C-peptide in long-standing type 1 diabetics with and without microvascular disease.
    Bodansky HJ; Medbak S; Drury PL; Cudworth AG
    Diabete Metab; 1981 Dec; 7(4):265-9. PubMed ID: 7333406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Platelet retention in diabetic patients. Its relation to microangiopathy].
    Cuesta Muñoz J; Faure Nogueras E; Llena Puy MC; Roche Asensio MJ; Zabala López S; Gutiérrez Martín M
    Rev Clin Esp; 1985 Nov; 177(7):321-5. PubMed ID: 4081210
    [No Abstract]   [Full Text] [Related]  

  • 6. Rheological changes in diabetic microangiopathy.
    Negrean V; Suciu I; Sâmpelean D; Cozma A
    Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alpha 2-antiplasmin in diabetes mellitus and its relation to diabetic retinopathy].
    Sánchez Martín S; García Díez LC; García Marcos MA; Miralles García JM
    Rev Clin Esp; 1983 May; 169(3):189-90. PubMed ID: 6612032
    [No Abstract]   [Full Text] [Related]  

  • 8. Diabetes mellitus. Lectures held in Cairo and Alexandria, January 1966.
    Poulsen JE
    Acta Endocrinol (Copenh); 1967; ():Suppl 118:5-95. PubMed ID: 5340062
    [No Abstract]   [Full Text] [Related]  

  • 9. [Beta cell activity in uremia. Determination of plasma insulin and C peptide after intravenous administration of glucose].
    Panzetta G; Mioni G; Cristinelli L; Broccoli R; Maiorca R; Valentini U; Rigosa C; Giustina G
    Minerva Nefrol; 1979; 26(3):339-42. PubMed ID: 400448
    [No Abstract]   [Full Text] [Related]  

  • 10. Beta cell function. Restoration and preservation of B-cells in children with type I diabetes.
    Jackson RL; Bilginturan NA; Terry CW; Hewett JE
    J Kans Med Soc; 1983 Jun; 84(6):321-30, 353. PubMed ID: 6348187
    [No Abstract]   [Full Text] [Related]  

  • 11. [Modification of hemorheological parameters in microvascular complications of diabetes].
    Bauduceau B; Renaudeau C; Mayaudon H; Hélie C; Ducorps M; Sonnet E; Yvert JP
    Diabete Metab; 1995 Jun; 21(3):188-93. PubMed ID: 7556810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of residual beta-cell function on the development of diabetic retinopathy.
    Madsbad S; Lauritzen E; Faber OK; Binder C
    Diabet Med; 1986 Jan; 3(1):42-5. PubMed ID: 2951134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil surface expression of CD11b and CD62L in diabetic microangiopathy.
    Mastej K; Adamiec R
    Acta Diabetol; 2008 Sep; 45(3):183-90. PubMed ID: 18496641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pancreatic beta cell function and the C-peptide content in the blood serum in thyrotoxicosis].
    Pavliuk PM; Slavnov VN; Epshteĭn EV
    Klin Med (Mosk); 1982 Apr; 60(4):51-4. PubMed ID: 7047893
    [No Abstract]   [Full Text] [Related]  

  • 15. Circulating C-peptide and diabetic retinopathy.
    Mosier MA
    Diabetes Res; 1984 Sep; 1(3):151-4. PubMed ID: 6529887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Indicators of the blood kinin system in diabetes mellitus].
    Spesivtseva VG; Men'shikov VV; Beliakov NV; Mamaeva GG; Stepanova NI
    Sov Med; 1976 Jun; (6):25-8. PubMed ID: 190712
    [No Abstract]   [Full Text] [Related]  

  • 17. [Islet beta-cell function in failures following sulfonylurea therapy in diabetics, by determination of serum C-peptide].
    Costamaillere L; Arteaga A; Velasco N; Pellegrino MR; Foradori A; López G; Acosta AM
    Rev Med Chil; 1984 Dec; 112(12):1206-13. PubMed ID: 6399604
    [No Abstract]   [Full Text] [Related]  

  • 18. Residual B-cell function in insulin dependent (Type 1) and non insulin-dependent (Type 2) diabetics (relationship between 24-hour C-peptide excretion and the clinical features of diabetes).
    Gerö L; Korányi L; Tamás G
    Diabete Metab; 1983 Sep; 9(3):183-7. PubMed ID: 6360742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of various hemorheologic parameters in diabetes mellitus].
    Cella A; Bianchi E; Reali GL; Piana A; Armani U
    Boll Soc Ital Biol Sper; 1990 Apr; 66(4):335-42. PubMed ID: 2390223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Specific features of hemocoagulation in patients with diabetic microangiopathies].
    Ivanova NA; Ias'ko AA; Gorokhovskaia GN
    Sov Med; 1977 Jan; (1):121-7. PubMed ID: 847507
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.